secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001213900-24-093567
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies secures up to $15M equity line from Square Gate Capital over 24 months
--------------------------------------------------------------------------------

- Company can sell up to $15M of common stock to Square Gate at 95% of lowest VWAP during valuation period.
- Investor prohibited from short sales or hedging; no warrants issued in the transaction.
- Initial commitment shares equal to 3% of $15M issued as consideration to the investor.
- Proceeds will fund clinical development programs and expand discovery and preclinical activities.
- Registration statement covering resale of shares to be filed with SEC by November 15, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390024093567/0001213900-24-093567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390024093567/ea0219546-8k_osthera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-093567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer